Eli Lilly and Company is leading a global effort to protect wildlife by shifting away from horseshoe crab blood and using a ...

Eli Lilly’s legal actions against Empower Pharmacy and other compounding pharmacies come several months after the FDA ...

BENGALURU] European shares ended slightly higher on Tuesday (Apr 22) on the back of rising financials and post-earnings gains ...

A recent medical trial could help deliver the first daily weight loss pill capable of cutting down obesity as effectively as ...

The most recent trading session ended with Eli Lilly (LLY) standing at $827.54, reflecting a +1.16% shift from the previouse trading day's closing. The stock lagged the S&P 500's daily gain of 2.51%.

Texas health officials said Tuesday reported measles cases have now surpassed 600 with most of it affecting children and ...

The health-care industry group of the S&P 500 has fought back to near the flat line for the year to date. Orchestra BioMed Holdings shares initially surged after the maker of medical devices said a ...

UnitedHealth's new security spending disclosures underscore how a fatal shooting in December caused companies to reassess the ...

For those looking to jumpstart their weight journey or finally reach their fitness goals, one option that is the center of ...

Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is ...

Eli Lilly gains analyst support after Phase 3 success. Bullish forecasts for obesity dominance and key earnings are set for ...

Novo Nordisk, maker of Ozempic, applied for FDA approval for a weight loss pill, less than a week after rival Eli Lilly's clinical trial success.